Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enovix (ENVX) Payables (2020 - 2025)

Historic Payables for Enovix (ENVX) over the last 6 years, with Q3 2025 value amounting to $21.3 million.

  • Enovix's Payables rose 4163.9% to $21.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.3 million, marking a year-over-year increase of 4163.9%. This contributed to the annual value of $9.5 million for FY2024, which is 5533.39% down from last year.
  • Enovix's Payables amounted to $21.3 million in Q3 2025, which was up 4163.9% from $13.9 million recorded in Q2 2025.
  • Over the past 5 years, Enovix's Payables peaked at $21.3 million during Q3 2025, and registered a low of $630205.0 during Q2 2021.
  • Over the past 5 years, Enovix's median Payables value was $11.4 million (recorded in 2023), while the average stood at $11.3 million.
  • Its Payables has fluctuated over the past 5 years, first soared by 87317.54% in 2022, then crashed by 5533.39% in 2024.
  • Enovix's Payables (Quarter) stood at $1.7 million in 2021, then surged by 297.9% to $6.8 million in 2022, then soared by 211.78% to $21.3 million in 2023, then crashed by 55.33% to $9.5 million in 2024, then skyrocketed by 124.52% to $21.3 million in 2025.
  • Its Payables stands at $21.3 million for Q3 2025, versus $13.9 million for Q2 2025 and $20.6 million for Q1 2025.